Designed Inhibitors of Pin1 in Mitosis

有丝分裂中 Pin1 的设计抑制剂

基本信息

项目摘要

DESCRIPTION (provided by applicant): Pin1 is an enzyme that catalyzes isomerization of phosphoserine/threonine-proline (pSer/Thr-Pro) amides. Pin1 is hypothesized to regulate signal transduction leading to mitosis by a conformational switch, isomerizing specific prolyl amides in cell cycle regulatory proteins. Pin1 has also been shown to regulate the activity of Alzheimer's associated tau protein. The unique peptidyl-prolyl isomerase (PPIase) enzymatic activity of Pin1 in the regulation of biological processes is interesting for fundamental reasons. Pin1 consists of two domains that both bind pSer/Thr-Pro motifs with distinct selectivity's. Specific ligands will be developed for each domain separately to be used as tools to study regulation by Pin1. In the first Specific Aim, we propose the design, parallel synthesis and assay of libraries of conformationally constrained trans- proline mimics targeted to the Pin1 WW domain. Parallel synthesis will use solid phase attachment through the invariant phosphate, and amide bond couplings to produce compounds of sufficient purity for screening. A high-throughput competitive enzyme-linked immunosorbent assay (ELISA) will be developed to assay WW domain binding. The WW domain ligands will also be tested for noncompetitive inhibition in the catalytic assay because we have shown inhibition of catalysis by a peptide binding to the WW domain. In the second Aim, libraries will be derived from compounds targeted to the catalytic domain that we have already synthesized: pSer-c/s-Pro isostere, reduced amide, ketone and alpha-ketoamide motifs. The catalytic domain inhibitors will be screened in a high-throughput enzymatic assay, and the mode of inhibition will be determined for the best inhibitors. In the third Aim, the two types of ligands for Pint will be combined into bivalent inhibitors to study the structural and dynamic interactions between the two domains of Pin1. The fourth Aim concerns development of phosphate prodrugs, masked to improve membrane permeability. We will also develop diflurophosphonates stabilized towards phosphatases. These two modifications will allow these compounds to be used in whole cells and in vivo. The best ligands will be useful in collaborations designed to elucidate the structure, function and dynamic relationships within Pin1 and between Pin1 and its ligands.
描述(由申请人提供):Pin 1是一种催化磷酸丝氨酸/苏氨酸-脯氨酸(pSer/Thr-Pro)酰胺异构化的酶。Pin 1被假设为通过构象开关调节导致有丝分裂的信号转导,异构化细胞周期调节蛋白中的特定脯氨酰酰胺。Pin 1也被证明可以调节阿尔茨海默氏症相关tau蛋白的活性。Pin 1在调节生物过程中独特的肽基脯氨酰异构酶(PPIase)酶活性是令人感兴趣的基本原因。Pin 1由两个结构域组成,这两个结构域都以不同的选择性结合pSer/Thr-Pro基序。将为每个域分别开发特定的配体,以用作研究Pin 1调控的工具。在第一个具体目标中,我们提出了针对Pin 1 WW结构域的构象受限的反式脯氨酸模拟物文库的设计、平行合成和测定。平行合成将通过不变的磷酸盐和酰胺键偶联使用固相连接,以产生足够纯度的化合物用于筛选。将开发高通量竞争性酶联免疫吸附测定(ELISA)来测定WW结构域结合。还将在催化测定中测试WW结构域配体的非竞争性抑制,因为我们已经显示了通过与WW结构域结合的肽对催化的抑制。在第二个目标中,文库将来自我们已经合成的靶向催化结构域的化合物:pSer-c/s-Pro电子等排体,还原的酰胺,酮和α-酮酰胺基序。将在高通量酶测定中筛选催化结构域抑制剂,并确定最佳抑制剂的抑制模式。在第三个目标中,将Pint的两种类型的配体组合成双价抑制剂,以研究Pin 1的两个结构域之间的结构和动力学相互作用。第四个目标涉及磷酸盐前药的开发,掩蔽以改善膜渗透性。我们还将开发对磷酸酶稳定的二氟膦酸盐。这两种修饰将允许这些化合物用于全细胞和体内。最好的配体将是有用的合作,旨在阐明结构,功能和动力学的Pin 1内的关系,Pin 1和它的配体之间。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

FELICIA A ETZKORN其他文献

FELICIA A ETZKORN的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('FELICIA A ETZKORN', 18)}}的其他基金

Liquid Chromatograph-Tandem Mass Spectrometer
液相色谱-串联质谱仪
  • 批准号:
    6441317
  • 财政年份:
    2002
  • 资助金额:
    $ 19.21万
  • 项目类别:
Designed Inhibitors of Pin1 in Mitosis
有丝分裂中 Pin1 的设计抑制剂
  • 批准号:
    7270460
  • 财政年份:
    2000
  • 资助金额:
    $ 19.21万
  • 项目类别:
Designed Inhibitors of Pin1 in Mitosis
有丝分裂中 Pin1 的设计抑制剂
  • 批准号:
    7477724
  • 财政年份:
    2000
  • 资助金额:
    $ 19.21万
  • 项目类别:
Designed Inhibitors of Pin1 in Mitosis
有丝分裂中 Pin1 的设计抑制剂
  • 批准号:
    7667517
  • 财政年份:
    2000
  • 资助金额:
    $ 19.21万
  • 项目类别:
Designed Inhibitors of Pin1 in Mitosis
有丝分裂中 Pin1 的设计抑制剂
  • 批准号:
    7126863
  • 财政年份:
    2000
  • 资助金额:
    $ 19.21万
  • 项目类别:
THE ROLE OF PIN1 IN MITOSIS WITH DESIGNED INHIBITORS
PIN1 在有丝分裂中与设计抑制剂的作用
  • 批准号:
    6335974
  • 财政年份:
    2000
  • 资助金额:
    $ 19.21万
  • 项目类别:
THE ROLE OF PIN1 IN MITOSIS WITH DESIGNED INHIBITORS
PIN1 在有丝分裂中与设计抑制剂的作用
  • 批准号:
    6387319
  • 财政年份:
    2000
  • 资助金额:
    $ 19.21万
  • 项目类别:
THE ROLE OF PIN1 IN MITOSIS WITH DESIGNED INHIBITORS
PIN1 在有丝分裂中与设计抑制剂的作用
  • 批准号:
    6526115
  • 财政年份:
    2000
  • 资助金额:
    $ 19.21万
  • 项目类别:
MIMICS OF HELIX TURN HELIX PEPTIDES
螺旋转角螺旋肽的模拟物
  • 批准号:
    6436988
  • 财政年份:
    1997
  • 资助金额:
    $ 19.21万
  • 项目类别:
MIMICS OF HELIX TURN HELIX PEPTIDES
螺旋转角螺旋肽的模拟物
  • 批准号:
    6180628
  • 财政年份:
    1997
  • 资助金额:
    $ 19.21万
  • 项目类别:

相似海外基金

Collaborative Research: Beyond the Single-Atom Paradigm: A Priori Design of Dual-Atom Alloy Active Sites for Efficient and Selective Chemical Conversions
合作研究:超越单原子范式:双原子合金活性位点的先验设计,用于高效和选择性化学转化
  • 批准号:
    2334970
  • 财政年份:
    2024
  • 资助金额:
    $ 19.21万
  • 项目类别:
    Standard Grant
NSF-BSF: Towards a Molecular Understanding of Dynamic Active Sites in Advanced Alkaline Water Oxidation Catalysts
NSF-BSF:高级碱性水氧化催化剂动态活性位点的分子理解
  • 批准号:
    2400195
  • 财政年份:
    2024
  • 资助金额:
    $ 19.21万
  • 项目类别:
    Standard Grant
Collaborative Research: Beyond the Single-Atom Paradigm: A Priori Design of Dual-Atom Alloy Active Sites for Efficient and Selective Chemical Conversions
合作研究:超越单原子范式:双原子合金活性位点的先验设计,用于高效和选择性化学转化
  • 批准号:
    2334969
  • 财政年份:
    2024
  • 资助金额:
    $ 19.21万
  • 项目类别:
    Standard Grant
Mechanochemical synthesis of nanocarbon and design of active sites for oxygen reducton/evolution reactions
纳米碳的机械化学合成和氧还原/演化反应活性位点的设计
  • 批准号:
    23K04919
  • 财政年份:
    2023
  • 资助金额:
    $ 19.21万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Creation of porous inorganic frameworks with controlled structure of metal active sites by the building block method.
通过积木法创建具有金属活性位点受控结构的多孔无机框架。
  • 批准号:
    22KJ2957
  • 财政年份:
    2023
  • 资助金额:
    $ 19.21万
  • 项目类别:
    Grant-in-Aid for JSPS Fellows
Catalysis of Juxaposed Active Sites Created in Nanospaces and Their Applications
纳米空间中并置活性位点的催化及其应用
  • 批准号:
    23K04494
  • 财政年份:
    2023
  • 资助金额:
    $ 19.21万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Generation of carbon active sites by modifying the oxygen containing functional groups and structures of carbons for utilizing to various catalytic reactions.
通过修饰碳的含氧官能团和结构来产生碳活性位点,用于各种催化反应。
  • 批准号:
    23K13831
  • 财政年份:
    2023
  • 资助金额:
    $ 19.21万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
CAREER: CAS: Understanding the Chemistry of Palladium and Silyl Compounds to Design Catalyst Active Sites
职业:CAS:了解钯和甲硅烷基化合物的化学性质以设计催化剂活性位点
  • 批准号:
    2238379
  • 财政年份:
    2023
  • 资助金额:
    $ 19.21万
  • 项目类别:
    Continuing Grant
CAS: Collaborative Research: Tailoring the Distribution of Transient vs. Dynamic Active Sites in Solid-Acid Catalysts and Their Impacts on Chemical Conversions
CAS:合作研究:定制固体酸催化剂中瞬时活性位点与动态活性位点的分布及其对化学转化的影响
  • 批准号:
    2154399
  • 财政年份:
    2022
  • 资助金额:
    $ 19.21万
  • 项目类别:
    Standard Grant
Engineering of Active Sites in Heterogeneous Catalysts for Sustainable Chemical and Fuel Production.
用于可持续化学和燃料生产的多相催化剂活性位点工程。
  • 批准号:
    RGPIN-2019-06633
  • 财政年份:
    2022
  • 资助金额:
    $ 19.21万
  • 项目类别:
    Discovery Grants Program - Individual
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了